CEO of 22nd Century Group Purchases 100,000 Company Stocks

Business by 2FIRSTS.ai
Jan.08.2024
CEO of 22nd Century Group Purchases 100,000 Company Stocks
22nd Century Group CEO Lawrence Firestone purchased 100,000 shares of company stock at an average price of $0.17 per share.

According to a report by the Associated Press on January 4, Lawrence Firestone, the CEO of 22nd Century Group (NASDAQ: XXII) bought 100,000 shares of the company's stock. The average purchase price per share was $0.17, resulting in a total transaction amount of $17,000.

 

According to reports, the 22nd Century Group is an agricultural biotechnology company that primarily focuses on utilizing plant science to reduce tobacco harm, lower nicotine content, and enhance overall health levels through plant science innovations in the life sciences and consumer goods industries.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Baltimore Moves to Zone Smoke Shops, Set Minimum Distance From Schools
Baltimore Moves to Zone Smoke Shops, Set Minimum Distance From Schools
Baltimore’s City Council in Maryland, building on recently enacted restrictions on “small box” dollar-store chains, has proposed a package of regulations for tobacco and vape retailers. The measures would create a standalone land-use category for “smoke shops,” establish distance buffers from schools and parks, limit exterior signage brightness, and schedule an informational hearing.
Oct.29 by 2FIRSTS.ai
DARE Warns Malaysia: Vaping Bans Will Expand Illicit Market; Strengthen Enforcement Within Existing Framework
DARE Warns Malaysia: Vaping Bans Will Expand Illicit Market; Strengthen Enforcement Within Existing Framework
Malaysia’s policy think tank Datametrics Research and Information Sdn Bhd (DARE) cautions that state- or nationwide bans on e-cigarettes would fuel the illicit market, weaken investor confidence, reduce tax revenues, and cost jobs. DARE argues that authorities should prioritize consistent enforcement under existing laws rather than impose new prohibitions.
Sep.28 by 2FIRSTS.ai
Product | Featuring an ultra-thin metal body and a “Champagne Gold” design, Sikary launches the Sikary Fit in the Middle East
Product | Featuring an ultra-thin metal body and a “Champagne Gold” design, Sikary launches the Sikary Fit in the Middle East
Sikary has listed its new disposable “Fit” on the official site and UAE channels. The device features a 13 mm metal body with a 12 mL e-liquid chamber and is advertised for up to 12,000 puffs, priced at around AED 35 per unit.
Oct.28 by 2FIRSTS.ai
Thai Cabinet Approves NHRC Proposal to Tighten E-Cigarette Regulation
Thai Cabinet Approves NHRC Proposal to Tighten E-Cigarette Regulation
Thailand’s Cabinet approved a National Human Rights Commission proposal to tighten e-cigarette regulation. The Health Ministry was instructed to raise public awareness on vaping risks and amend the 2017 Tobacco Control Act to cover all tobacco products, including vapes and new forms, while enforcing WHO FCTC Article 5.3 to prevent industry interference.
Oct.28 by 2FIRSTS.ai
U.S. Conservative Commentator Charlie Kirk on Vaping Policy: Crackdown on Independent Vape Firms Could Force Adult Users Back to Cigarettes and the Black Market
U.S. Conservative Commentator Charlie Kirk on Vaping Policy: Crackdown on Independent Vape Firms Could Force Adult Users Back to Cigarettes and the Black Market
Charlie Kirk published an opinion piece in April criticizing current e-cigarette regulations, arguing that excessive oversight and litigation are not genuinely aimed at protecting youth but rather driven by political and corporate interests. He noted that this approach would force millions of adult users to lose access to low-risk alternatives, potentially pushing them back to cigarettes or toward black market products, ultimately harming public health.
Sep.11 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai